None of the CMN patients with duplications have so far developed melanoma; however, this is in line with what would be expected statistically, as the incidence of melanoma in CMN at this age is very low,36 and no conclusions can yet be drawn about potential association between the PPP2R3B duplications and outcome in CMN. This evidence concerns the gene PPP2R3B and congenital mesoblastic nephroma.